By Professor Ric Day

Journal articles

Runciman WB; Coiera E; Day RO; Hannaford NA; Hibbert PD; Hunt T; Westbrook JI; Braithwaite J, 2012, 'Towards the delivery appropriate healthcare in Australia', Medical Journal of Australia, 197, pp. 78 - 81, http://dx.doi.org/10.5694/mja12.10799

Baysari MT; Westbrook J; Day RO, 2012, 'Understanding doctors perceptions of their prescribing competency and the value they ascribe to an electronic prescribing system', Studies in Health Technology and Informatics,Volume 178: Health Informatics: Building a Healthcare Future Through Trusted Information, 178, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-078-9-1

Lipworth WL; Kerridge IH; Day RO, 2012, 'Wrong questions, wrong answers? Are we getting the drugs we need?', Clinical Pharmacology and Therapeutics, 91, pp. 367 - 369, http://dx.doi.org/10.1038/clpt.2011.335

Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff PA; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651, http://dx.doi.org/10.5694/mja10.10968

Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment', Medical Journal of Australia, 195, pp. 446 - 447, http://dx.doi.org/10.5694/mja11.10068

Day R; Pomerantz P, 2011, 'Thomas W. Teal In Memoriam', DRUG INFORMATION JOURNAL, 45, pp. II - II, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000292237400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ramasamy S; Kannangara D; Indraratna P; Stocker S; Jones G; Graham G; Williams K; Day R, 2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, 41, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Datta I; Indraratna P; Stocker S; Portek I; Graham G; Williams K; Day R, 2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, 41, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith MWH; Roberts DM; Ritson SM; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine', Medical Journal of Australia, 194, pp. 612 - 613, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03121.x

Milder T; Lipworth WL; Williams KM; Ritchie JE; Day RO, 2011, '"It looks after me": how older patients make decisions about analgesics for osteoarthritis.', Arthritis Care and Research, 63, pp. 1280 - 1286, http://dx.doi.org/10.1002/acr.20514

Roberts DM; Smith MA; McMullan B; Sevastos J; Day RO, 2011, 'Acute kidney injury due to crystalluria following acute valacycolvir overdose', Kidney International, 79, pp. 574 - 575, http://dx.doi.org/10.1038/ki.2010.496

Graham GG; Punt J; Manit A; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup L; Carl m kirkpatrick CM; Ray J; Timmins P; Williams KM, 2011, 'Clinical pharmacokinetics of metformin', Clinical Pharmacokinetics, 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000

Henneicke H; Herrmann M; Kalak R; Brennan-Speranza TC; Heinevetter U; Bertollo N; Day RE; Huscher D; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H, 2011, 'Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism', Bone, 49, pp. 733 - 742, http://dx.doi.org/10.1016/j.bone.2011.06.013

Roberts DM; Smith MA; Ritson R; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine: 3 cases over 2 weeks', Medical Journal of Australia, 194, pp. 612 - 613

Day RO; Lipworth WL; Kerridge IH, 2011, 'Death of the ‘Blockbuster’ and ‘Pivotal’ Clinical Trial: Rethinking the Drug Development Process.', Journal of Pharmacy Practice and Research, 41, pp. 94 - 95, http://search.informit.com.au/documentSummary;dn=210193844187640;res=IELHEA

Wang N; Lipworth WL; Ritchie JE; Williams K; Day RO, 2011, 'Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines', Internal Medicine Journal, 41, pp. 314 - 320, http://dx.doi.org/10.1111/j.1445-5994.2010.02239.x

Roberts DM; Smith MA; Gopalakrishnan M; Whittaker G; Day RO, 2011, 'Extreme y-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis', Annals of Emergency Medicine, 58, pp. 83 - 85, http://dx.doi.org/10.1016/j.annemergmed.2011.01.017

Lipworth WL; Kerridge IH; Brett J; Day RO, 2011, 'How clinical and resaerch failures lead to suboptimal prescribing: the example of chronic gout', British Medical Journal, 343, pp. 1 - 3

Lipworth WL; Kerridge I; Brett J; Day R, 2011, 'How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.', British Medical Journal, 343, pp. d7459, http://dx.doi.org/10.1136/bmj.d7459

Day RO; Roffe D; Richardson K; Baysari MT; Brennan NJ; Beveridge AH; Melocco T; Ainge J; Westbrook J, 2011, 'Implementing electronic medication management at an Australian teaching hospital', Medical Journal of Australia, 195, pp. 498 - 502, http://dx.doi.org/10.5694/mja11.10451

Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6

Lee P; Kengne A; Greenfield JR; Day RO; Chalmers J; Ho KK, 2011, 'Metabolic sequelae of beta-blocker theraphy: weighing in on the obesity epidemic?', International journal of obesity, 35, pp. 1395 - 1403, http://dx.doi.org/10.1038/ijo.2010.284

Brett J; Beresford R; Sevastos J; Day RO, 2011, 'Neem Extract Poisoning as a Cause of Renal Tubular Acidosis', Journal of Clinical Toxicology, 1, pp. 112, http://dx.doi.org/10.4172/2161-0495.1000112

Stocker SL; Graham GG; McLachlan AJ; Williams K; Day RO, 2011, 'Pharmacokinetic and Pharmacodynamic interaction between allopurinol and probenecid in patients with gout', Journal of Rheumatology, 38, pp. 904 - 910, http://dx.doi.org/10.3899/jrheum.101160

Bell AJ; Mcd taylor D; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Procedural sedation practices in Australian Emergency Departments', Emergency Medicine Australasia, 23, pp. 458 - 465, http://dx.doi.org/10.1111/j.1742-6723.2011.01418.x

Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in the treatment of rheumatoid arthritis: a failure of practice or failure of evidence?', Medical Journal of Australia, 195, pp. 446 - 447

Mcd taylor D; Bell AJ; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Risk factors for sedation-related events during procedural sedation in the emergency departmentemm_1419 466..473', Emergency Medicine Australasia, 23, pp. 466 - 473, http://dx.doi.org/10.1111/j.1742-6723.2011.01419.x

Bombardier C; Laine L; Day RO; Hawkey CJ; Hochberg MC; Schnitzer TJ, 2011, 'Rofecoxib and clinically significant gastrointestinal events', American Journal of the Medical Sciences, 342, pp. 438 - 439, http://dx.doi.org/10.1097/MAJ.0b013e31822f3ff4

Harvey K; Day RO; Campbell W; Lipworth WL, 2011, 'Saving money on the PBS: Ranibizumab or Bevacizumab for Neovascular Macular Degeneration?', Medical Journal of Australia, 194, pp. 567 - 568

Baysari MT; Westbrook J; Richardson K; Day RO, 2011, 'The influence of computerized decision support on prescribing during ward rounds: are the decision-makers targeted?', Journal of the American Medical Informatics Association, 18, pp. 754 - 759, http://dx.doi.org/10.1136/amiajnl-2011-000135

Baysari MT; Westbrook J; Braithwaite J; Day R, 2011, 'The Role of Computerized Decision Support in Reducing Errors in Selecting Medicines for Prescription: Narrative Review', Drug Safety, 34, pp. 289 - 298, http://dx.doi.org/10.2165/11588200-000000000-00000

Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA

Milder T; Williams K; Ritchie JE; Lipworth WL; Day RO, 2011, 'Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: Engagement with information and perceptions of risk', Age and Ageing, 40, pp. 254 - 259, http://dx.doi.org/10.1093/ageing/afq160

Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff P; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651

Lipworth WL; Wodak A; Haber P; Day RO, 2011, 'Why is Disulfiram not on the PBS?', Medical Journal of Australia, 195, pp. 371 - 372

Roberts D; Chau A; Nair P, 2010, 'ENHANCED ELIMINATION OF PHENOBARBITAL USING CHARCOAL HAEMOPERFUSION IN A PATIENT WITH SEVERE POISONING', NEPHROLOGY, 15, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Lu VH; Goldberg I; Day RO, 2010, 'Towards integrated care: Australia's new model of care for patients with glaucoma', Medical Journal of Australia, 193, pp. 200 - 201, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03867.x

Standfield L; Norris S; Harvey C; Elliot L; Riordan J; Hall S; Day R; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study', Clinical Therapeutics, 32, pp. 1329 - 1342, http://dx.doi.org/10.1016/j.clinthera.2010.07.006

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6)', Inflammopharmacology, 18, pp. 57, http://dx.doi.org/10.1007/s10787-010-0039-3

Carter SM; Samuel GN; Kerridge I; Day R; Ankeny RA; Jordens CFC; Komesaroff P, 2010, 'Beyond rhetoric in debates about the Ethics of marketing prescription medicines to consumers: The importance of Vulnerability in people, situations, and relationships', AJOB Primary Research, 1, pp. 11 - 21, http://dx.doi.org/10.1080/21507716.2010.482871

Day RO; Liauw WS; Tozer L; McElduff P; Beckett RJ; Williams K, 2010, 'A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenpausal women', BMC Research Notes, 3, pp. 1 - 8

Indraratna P; Stocker SL; Williams KM; Graham GG; Jones G; Day RO, 2010, 'A proposal for identifying the low renal uric acid clearance phenotype', Arthritis Research and Therapy, 12, pp. 149 - 151

Wallace H; Graham GG; Williams K; Day RO, 2010, 'A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine', Pain Medicine, 11, pp. 951 - 965

Westbrook JI; Woods A; Rob MI; Dunsmuir WTM; Day RO, 2010, 'Association of interruptions with an increased risk and severity of medication administration errors', Archives of Internal Medicine, 170, pp. 683 - 690, http://dx.doi.org/10.1001/archinternmed.2010.65

Magrabi F; Li S; Day RO; Coiera E, 2010, 'Errors and electronic prescribing: A controlled laboratory study to examine task complexity and interruption effects', American Medical Informatics Association Annual Symposium Proceedings, 17, pp. 575 - 583

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'FDA proposals to limit the hepatoxicity of paracetamol (acetaminophen). Are they resonable?', Inflammopharmacology, 18, pp. 47 - 55

Stocker S; Franklin M; Anderson JM; Pillans PI; Williams K; McLachlan AJ; Day RO; taylor P, 2010, 'Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry', Journal of Chromatography, 878, pp. 2363 - 2368

Williams CM; Latimer J; Maher C; McLachlan AJ; Cooper C; Hancock M; Day RO; McAuley J; Lin C, 2010, 'PACE-the first placebo controlled trail of paracetamol for acute low back pain:design of a randomised controlled trial', BMC Musculoskeletal Disorders, 11, pp. 1 - 11, http://www.biomedcentral.com/content/pdf/1471-2474-11-169.pdf

Abdul M; Jiang XM; Williams KM; Day RO; Roufogalis B; Liauw WS; Xu H; Matthias A; Lehmann RP; McLachlan AJ, 2010, 'Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects', British Journal of Clinical Pharmacology, 69, pp. 508 - 515

Standfield L; Norris S; Elliott L; Riordan J; Hall S; Day RO; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health related utility and resource use in Australian rheumatoid arthritis patients', Clinical Therapeutics, 32, pp. 1329 - 1342

Back to profile page